Price (90d)
$32.59Signal Score (90d)
110Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $965.41M | $-284.28M | $-17.30 |
| 2024 | $930.62M | $-1.65B | $-101.92 |
| 2023 | $961.52M | $-91.70M | $-5.69 |
| 2022 | $1.08B | $-572.91M | $-35.87 |
| 2021 | $1.12B | $102.08M | $6.40 |
Social Signal Score
Earnings
Fri, Nov 6(in 3 months)
Consensus estimate $-3.69 per share
Typical surprise -35.6% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Aug 7$-3.49 vs $-4.12beat
- Thu, May 7$-4.41 vs $-3.81miss
- Mon, Feb 23$-4.88 vs $0.85miss
- Fri, Nov 7$-4.23 vs $-3.12miss
- Wed, Aug 6$-3.81 vs $-2.69miss
- Thu, May 8$-4.38 vs $-2.20miss
Estimates and results for CTEV via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
CTEVhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (2)
- Newsmarketbeat.com·7d ago·Neutral
Claritev Q2 Earnings Call Highlights Claritev NYSE: CTEV reported second-quarter revenue growth, record bookings and higher cash flow, prompting the healthcare technology company to raise its full-year revenue, adjusted EBITDA and free-cash-flow outlook.
View source ↗ - Newsseekingalpha.com·7d ago·Positive
Claritev Corporation (CTEV) Q2 2026 Earnings Call Transcript Claritev Corporation (CTEV) Q2 2026 Earnings Call Transcript
View source ↗
